✦ LIBER ✦

1074 Evaluation of pre- and post-treatment serum levels of CYFRA 21–1 in lung cancer (LC) patients (PTS)

✍ Scribed by Paesmans, M.; Sculier, J.P.; Borges, M.; Frühling, J.

Book ID: 124125464
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 149 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)96321-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Value of Cyfra 21-1 (CY21) as determinan

Value of Cyfra 21-1 (CY21) as determinant of survival and predictor of disease course in lung cancer (LC) patients (pts)

✍ Barradas, P; Cristóvão, M; Costa, A; Fragoso, A.L; Alves, P; Melo, M.J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 107 KB

592Evaluation of serum levels of cyfra 2

592Evaluation of serum levels of cyfra 21-1 during radiotherapy treatment in squamous cell lung carcinoma

✍ Jacobs, I.; Goor, C.; Van den Weyngaert, D. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Evaluation of the serum markers CEA, NSE

Evaluation of the serum markers CEA, NSE, TPS and CYFRA 21.1 in lung cancer

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Pre and post operative values of cyfra 2

Pre and post operative values of cyfra 21-1, CEA, SCC, TPA and NSE in primary lung cancer

✍ Rastel, D.; Comoy, E.; Levasseur, Ph.; Fatal, P. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Evaluation of cytokeratin 19 serum fragm

Evaluation of cytokeratin 19 serum fragments (CYFRA 21-1) in patients with lung cancer: Results of a multicenter trial

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Low utility of CYFRA 21-1 serum levels f

Low utility of CYFRA 21-1 serum levels for diagnosis and follow-up in bladder cancer patients

✍ Daniel Fatela-Cantillo; Antonio Fernández-Suárez; Violeta Menéndez; Juan Antonio 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

## Abstract We evaluated serum levels of soluble fragments of cytokeratin 19 (CYFRA 21‐1) by immunoassay (ES‐700; Roche Diagnostics, Mannheim, Germany) to assess its usefulness in the diagnosis and follow‐up of bladder cancer. The study included 39 patients with a diagnosis of transitional cell car